Octreotide for the treatment of chylothorax in two preterm infants

被引：0
|
作者：
Haase, R. [1 ]
Lieser, U. [1 ]
Buttenhoff, S. [1 ]
Merkel, N. [1 ]
机构：
[1] Univ Halle Wittenberg, Univ Klin Kinder & Jungendmed, D-06097 Halle, Germany
来源：
MONATSSCHRIFT KINDERHEILKUNDE | 2011年 / 159卷 / 04期
关键词：
Chylothorax; Thoracotomy; Somatostatin; Octreotide; Premature birth; POSTOPERATIVE CHYLOTHORAX; PLEURAL EFFUSIONS; NEONATAL-PERIOD; CHILDREN; SOMATOSTATIN; MANAGEMENT;
D O I：
10.1007/s00112-010-2358-2
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
In recent years the use of somatostatin (SST) or its analogue octreotide (OCT) has been described for the treatment of refractory chylothorax in neonates. Indication, dose and length of treatment are not precisely defined as yet. To date only few cases of OCT or SST use in preterm infants with a gestational age < 32 weeks have been published. Treatment was successful in these patients without serious adverse effects. We report two preterm (gestational age 27 and 25 weeks) infants with chylothorax following surgical ligation of a patent arterial duct. Both patients were treated successfully with OCT (96 A mu g/kg per day).
引用
收藏
页码：364 / 367
页数：4
相关论文
共 50 条
  • [31] Octreotide Treatment of Chylothorax in Pediatric Patients following Cardiothoracic Surgery
    Caverly, Lindsay
    Rausch, Christopher M.
    da Cruz, Eduardo
    Kaufman, Jon
    CONGENITAL HEART DISEASE, 2010, 5 (06) : 573 - 578
  • [32] Successful treatment of chylothorax after esophagectomy using octreotide and etilefrine
    Hirotaka Tabata
    Toshiyasu Ojima
    Mikihito Nakamori
    Masaki Nakamura
    Masahiro Katsuda
    Keiji Hayata
    Shuichi Matsumura
    Tomoya Kato
    Junya Kitadani
    Akihiro Takeuchi
    Makoto Iwahashi
    Hiroki Yamaue
    Esophagus, 2016, 13 : 306 - 310
  • [33] Congenital chylothorax treated with octreotide
    Sahin Y.
    Aydin D.
    The Indian Journal of Pediatrics, 2005, 72 (10) : 885 - 888
  • [34] Octreotide in the management of postoperative chylothorax
    Rosti, L
    De Battisti, F
    Butera, G
    Cirri, S
    Chessa, M
    Delogu, A
    Drago, M
    Giamberti, A
    Pomè, G
    Carminati, M
    Frigiola, A
    PEDIATRIC CARDIOLOGY, 2005, 26 (04) : 440 - 443
  • [35] Octreotide in the Management of Postoperative Chylothorax
    L. Rosti
    F. De Battisti
    G. Butera
    S. Cirri
    M. Chessa
    A. Delogu
    M. Drago
    A. Giamberti
    G. Pomè
    M. Carminati
    A. Frigiola
    Pediatric Cardiology, 2005, 26 : 440 - 443
  • [36] Congenital chylothorax treated with octreotide
    Aqrabawi, Hashem E.
    Hadidi, Aghadeer
    RAWAL MEDICAL JOURNAL, 2014, 39 (02): : 220 - 221
  • [37] Somatostatin or octreotide as treatment options for chylothorax in young children: a systematic review
    Charles C. Roehr
    Andreas Jung
    Hans Proquitté
    Oliver Blankenstein
    Hannes Hammer
    Kokila Lakhoo
    Roland R. Wauer
    Intensive Care Medicine, 2006, 32 : 650 - 657
  • [38] Efficacy and Predictor of Octreotide Treatment for Postoperative Chylothorax After Thoracic Esophagectomy
    Fujita, Takeo
    Daiko, Hiroyuki
    WORLD JOURNAL OF SURGERY, 2014, 38 (08) : 2039 - 2045
  • [39] EFFICACY AND SAFETY OF ADJUVANT OCTREOTIDE WITH PARENTERAL NUTRITION FOR CONSERVATIVE TREATMENT OF CHYLOTHORAX
    Lopez Lopez, Ma. V.
    Luengo Perez, L. M.
    Rangel Mayoral, J. F.
    Liso Rubio, F. J.
    NUTRICION HOSPITALARIA, 2012, 27 (03) : 948 - 949
  • [40] A Patient with Systemic Sclerosis and Chylothorax: Successful Treatment with Parenteral Nutrition and Octreotide
    Stach, C.
    Schildmann, J.
    Rascu, A.
    Manger, B.
    AKTUELLE RHEUMATOLOGIE, 2011, 36 (03) : 193 - 195
12345